Featured Research

from universities, journals, and other organizations

Local Anesthetics Are Effective For Neuropathic Pain

Date:
October 26, 2005
Source:
Center for the Advancement of Health
Summary:
Lidocaine and similar local anesthetics are effective for treating pain that emanates from damaged nerves, according to a systematic review of current evidence.

Lidocaine and similar local anesthetics are effective for treating pain that emanates from damaged nerves, according to a systematic review of current evidence.

Related Articles


Neuropathic pain, which can occur with chronic diseases or conditions, is frequently unresponsive to treatment and worsens over time.

“Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system,” found authors Ivo W. Tremont-Lukats, M.D., of the M.D. Anderson Cancer Center in Houston, and colleagues. They add that the drugs, “were safe in controlled clinical trials for neuropathic pain, were better than placebo and were as effective as other analgesics.”

The review appears in the most recent issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The authors reviewed 30 studies on the effectiveness of lidocaine and similar drugs mexiletine, tocainide and flecainide in treating pain. Local anesthetics work by decreasing sensation in a small area of the body.

The studies covered 371 patients given local anesthetics and 379 patients given placebos.
The patients studied had pain from cerebrovascular lesions or tumors, spinal cord injuries, multiple sclerosis, amputation and a variety of other causes, including pain for which there was no apparent cause.

Patients rated the intensity of spontaneous pain or its relief. Lidocaine administered by pump and mexiletine provided the best relief. However, there were some side effects reported, the most common being sleepiness, fatigue, nausea, numbness around the mouth, metallic taste and dizziness.

“For some patients in certain pain categories, lidocaine may be as good as other current therapies,” Tremont-Lukats says, “This systematic review found that lidocaine and mexiletine were equally effective, unlike other reviews previously stating that mexiletine seemed to work better.”

There are myriad challenges when treating neuropathic pain, according to Tremont-Lukats. “Its chronic nature, the immense variation between individuals and our incomplete knowledge on the pathophysiology of pain, despite progress made in the last 10 years, make pain difficult to treat,” he says. “Another important challenge is that many doctors are not trained to recognize and treat neuropathic pain. It is even more worrisome that many patients are undertreated or their pain is not taken seriously.”

V. Tim Malhotra, M.D., of the Memorial Sloan-Kettering Cancer Center in New York, agrees that treating neuropathic pain can be tough. “Getting complete relief of neuropathic pain is very difficult; often when we increase doses, we increase side-effects, many of which affect mental function.”

The exact number of people in the United States with neuropathic pain is unknown, but estimates hover around a minimum of 3 million, according to the Society for Neuroscience.

Neuropathic pain is a complex, chronic pain state often with no obvious cause; often, nerve fibers themselves may be damaged, dysfunctional or injured and send incorrect signals to other pain centers. Typical causes are alcoholism; amputation; back, leg, and hip problems; cancer chemotherapy; diabetes; facial nerve problems; HIV infection or AIDS; multiple sclerosis; shingles; spine injury or surgery.

The drugs studied in the review article have been in used in other settings: lidocaine both as a topical and pump-administered medication typically for shingles, and mexiletine, tocainide and flecainide as antiarrhythmics drugs, used to control irregular heartbeat by slowing nerve impulses and making heart tissue less sensitive.


Story Source:

The above story is based on materials provided by Center for the Advancement of Health. Note: Materials may be edited for content and length.


Cite This Page:

Center for the Advancement of Health. "Local Anesthetics Are Effective For Neuropathic Pain." ScienceDaily. ScienceDaily, 26 October 2005. <www.sciencedaily.com/releases/2005/10/051023122217.htm>.
Center for the Advancement of Health. (2005, October 26). Local Anesthetics Are Effective For Neuropathic Pain. ScienceDaily. Retrieved December 18, 2014 from www.sciencedaily.com/releases/2005/10/051023122217.htm
Center for the Advancement of Health. "Local Anesthetics Are Effective For Neuropathic Pain." ScienceDaily. www.sciencedaily.com/releases/2005/10/051023122217.htm (accessed December 18, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, December 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com
Dads-To-Be Also Experience Hormone Changes During Pregnancy

Dads-To-Be Also Experience Hormone Changes During Pregnancy

Newsy (Dec. 18, 2014) A study from University of Michigan researchers found that expectant fathers see a decrease in testosterone as the baby's birth draws near. Video provided by Newsy
Powered by NewsLook.com
Prenatal Exposure To Pollution Might Increase Autism Risk

Prenatal Exposure To Pollution Might Increase Autism Risk

Newsy (Dec. 18, 2014) Harvard researchers found children whose mothers were exposed to high pollution levels in the third trimester were twice as likely to develop autism. Video provided by Newsy
Powered by NewsLook.com
UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins